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As the world’s population ages, cataract-induced visual 
dysfunction and blindness is on the increase. This is a 
significant global problem. The most common symptoms 
of cataracts are glared and blurred vision.  Usually, people 
with cataract have trouble seeing or reading at distance or 
in low light and also their color perception is altered. 
Furthermore, cataract is a sneaky disease as it is usually a 
very slow but progressive process, which creates 
adaptation so that patients find it difficult to recognize. 
Moreover, for the doctors it can be very difficult to explain 
and give comprehensive answers to the patients’ 
symptoms. We built and tested an optic device that uses 
egg albumen to mimic the optical degradation of the 
crystalline related cataracts and that is able to visualize 
how the cataract impairs vision. At best of our knowledge, 
it is the first experimental system developed at this aim. 
This can be a valuable tool, which can be of help in 
education for students in medical sciences as well as to 
provide a method to illustrate the patients how their 
vision is affected by cataract progression process. 
OCIS codes: (330.7310) Vision; (170.4470) Ophthalmology; (000.2170) 
Equipment and techniques; (000.2060) Education;  
 
Cataract is the world’s leading cause of blindness. According 
to World Health Organization (WHO), it is responsible for the 
51% of the estimated 39 million cases of blindness occurring 
worldwide [1]. It is a gradual and inevitable process, should we 
be fortunate enough to live a long life [2]. 
Cataract is a disease associated with aging and with photo-
oxidative denaturation (and cross-linking) of lens crystallins 
and other proteins. Both cataract and aging of lens cells are 
associated with declining proteolytic capacity and diminished 
antioxidant protection. Lens aging and in vivo photo-oxidative 
stress can cause opalescence ("cataract"), cross-linking of 
crystallins, and diminished proteolytic capacity [3]. 
The most common symptoms of cataracts are glared and 
blurred vision.  Usually reading or seeing at distance become 
difficult, need of more light is sensed and color vision is also 
affected. So, how much does cataract affect vision? How does a 
subject with cataract experience this gradual sight impairment?  
Indeed, in the case of cataract, it is extremely difficult to 
evaluate the subjective vision loss as it depends on many factors 
such as location and spatial distribution. Besides, cataract’s slow 
but progressive process creates adaptation and, hence, the 
sufferers do not easily recognize it. Moreover, doctors can find 
difficult to explain and give comprehensive answers to the 
patients’ symptoms, as they have not experienced such 
multifaceted vision loss themselves.  
How to make patients aware of their progressive vision lost? 
It would be quite useful for patients’ awareness to have an 
experimental demonstrator for illustrating and displaying to 
patients how their vision is affected by cataract progression 
process. Here we show an experimental technique, including a 
simple eye cell model, that mimics the optical degradation of the 
crystalline related cataracts and that is able to visualize how the 
cataract impairs vision. This can be a valuable tool, which can be 
of help in education for students in medical science as well as to 
provide a method to illustrate the patients the vision disease 
thus enforcing their awareness in affording it.   
In general, the quality of the image on the retina is degraded 
because of scattering, diffraction at the pupil, defocus due to 
accommodation or ametropia, and aberrations of the eye [4–8]. 
With age, the crystalline lens undergoes changes that result in a 
degradation of the optical performance of the human eye.  
Over the course of life, UV in sunlight, chemicals, trauma or 
radiation experienced by each individual start to denature the 
proteins in lens [9].  Denaturing means that the nature of the 
proteins change and gradually the lens loses its transparency 
thus starting to scatter light. This explains how cataracts form. 
In this case, scattering becomes an important contributor of 
image degradation and the crystalline lens progressively loses 
transparency and becomes opalescent [6–8,10,11].  
Pathological studies of cataractous lenses have revealed that 
cataracts are composed of protein aggregates that precipitate in 
eye lens cells [12–14]. The prevalent proteins within the eye 
lens are the crystallins. Lens transparency is thought to be 
maintained by a liquid-like, short range order present in highly 
concentrated solutions of these proteins[15–17]. In mammals, 
-crystallin is the 
most abundant.  
Age related modifications of -crystallin induce alterations in 
lens crystallin interactions, which can be responsible for the 
increase in light scattering in old and cataractous lenses [18–
21]. Alterations include both changes in the secondary structure 
and in the state of aggregation [22], [23]. They are triggered by 
lens cells exposition to elevated temperatures or other stress 
factors such as UV light or Cosmic radiation (e.g. it has been 
shown an increase of the risk of nuclear cataract in airline pilots 
[24]), which disrupt the liquid-like molecular order and 
promote the formation of large scattering particles [25–27].  
Fig. 1:  Sketch of the experimental setup (top) and technical draw of the 
eye cell model (bottom). 
Quite remarkably, temperature is a very simple way to 
reproduce many of the age-related lens changes. Simply 
exposing lenses to heat can replicate many changes that take 
place -
crystalline, membrane fluidity, binding of proteins to cell 
membranes and decomposition of membrane phospholipids. 
Time and temperature are linked variables. It has been shown 
that short-term exposure to 50°C in the laboratory can 
reasonably be used to study processes in an experimental 
period that in the normal eye may take decades at 35-42°C [28]. 
Given the rapidity with which major lens changes can be 
induced under laboratory conditions at 50°C, it would not be 
surprising if such variation in ocular temperature could indeed 
modulate the rate of change of protein denaturation in the lens.  
This same denaturation process occurs to albumen when an 
egg is boiled. In the past, albumen have been used as phantom 
for the study of tissue response and photocoagulation induced 
by laser light [29,30]. In fact, it has a well-known behavior of 
protein denaturation as function of temperature and time, 
which is related to its scattering and adsorbing properties [31–
33].  
Here, we use egg albumen as realistic phantom material in 
order to reproduce the changes of visual impairment due to 
aging in very good analogy with the protein denaturation that 
occurs in the eye lens. We built a cell formed by a sealed box with 
transparent walls, one being a plano-convex lens and the other 
a glass microscope slide. The cell is filled with albumen through 
two small perfusion holes placed on top. On the inside, 
furthermore, a thin tungsten wire connected to a voltage 
generator provides heating by Joule effect. A LED lamp is used 
to illuminate a slide and form the image. To obtain homogenous 
illumination, a diffuser was placed between the slide and the 
lamp. Finally, a camera is placed in correspondence of the image 
plane of the eye cell (see Fig. 1).  
Fig. 2: Contrast behavior as function of time for different 
dilutions: 4:1 (red), 2:1 (green), 4:3 (gray), 1:1 (yellow), 1:2 
(blue).  
 
In order to reproduce the progressive effect of protein 
accumulation at the center of the crystalline in aging subjects, 
some arrangements must be made. In fact, to obtain sufficiently 
sharp images the albumen should be diluted to reduce the light 
scattering at room temperature. On the other hand, if it is diluted 
too much the effect of protein denaturation could become 
negligible. We have tested different albumen/water dilutions: 
4:1, 2:1, 4:3, 1:1, and 1:2. To quantify the effect of scattering due 
to protein denaturation on the image quality, we used a test 
slide with a line pattern on it (2.5 lin/mm). For each dilution, we 
evaluated the image contrast as the standard deviation of the 
intensity, calculated on the area correspondent to the pattern 
(see Fig. 2). The working voltage was fixed at 1V.  
Taking into account the time-behavior of contrast and image 
sharpness at initial stage of the measurements, the plot in Figure 
2 shows a better compromise for dilution 1:1. Using these value 
of dilution, we simulated the cataract-like degradation of image 
quality using a real-life scenario (Figures 3, Visualization 1). As 
time passes, proteins start denaturing and accumulating in 
correspondence of the center of the eye cell. In figure 3c, the 
image shows at first a slight increase of contrast (+7%) with a 
concurrent loss of brightness (-4%). The image quality, then, 
keeps on worsening until the amount of denatured proteins fills 
the center of the cell and scattering is so strong that light does 
not reach the camera anymore.  
Cataract induces also an alteration of color perception. The 
images formed by the sufferers eyes result dimmer and 
yellowed. This is due to scattering of light inside the crystalline, 
which is more severe for smaller wavelengths. This deviates 
blue light more the red one, producing, thus, a notable image 
yellowing. We have quantified color balance comparing the 
intensities of the three color channels of the camera, see Fig.3 
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insets. In Fig. 3b, the three channels are equally present in the 
image, although a slight prevalence of the blue one due to the 
sky. As time passes and scatter increases, the image loses 
definition and color balance starts to tend toward the red even 
though the effect is barely perceivable, see Fig. 3c. As the 
denaturation process goes on, albumen proteins scatter light to 
the extent that image formation is almost hindered and color 
balance is definitely uneven, Fig. 3d. This is consistent with the 
aforementioned cataract-related vision impairment symptoms 
such as dim vision and color yellowing.  
This experimental setup, then, proved itself capable to 
reproduce the image degradation process due to denatured 
proteins accumulation, either for optical resolution, glare effects 
and color distortion. Given the right experimental parameters, 
i.e. 1V tension, diffused illumination, and albumen/water 
dilution within 2:1 and 1:1, it shows a gradual loss of image 
contrast due to light scattering. We have shown that it features 
all the main characteristics of sight weakening experienced by 
cataract sufferers: glaring, blurring, dim vision, color alteration, 
and, finally, blindness. The gradual and sequential appearance 
of such features seems to mimic well the steady and relentless 
effect of aging upon vision, making it suitable as a tool for the 
assessment and illustration of age-related evolution in vision 
impairment caused by cataracts.  
Supplementary material. See Supplementary 1 for 
supporting content. 
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